Eye Supplement Also Protects Against Cancer

Why It Matters

Demonstrating a link between a common dietary carotenoid and cancer outcomes could reshape preventive nutrition advice and open inexpensive adjuncts for oncology treatments.

Key Takeaways

• Zeaxanthin may boost efficacy of cancer immunotherapies, per preclinical data
• Higher blood zeaxanthin levels correlate with lower overall cancer risk
• Observational studies link zeaxanthin intake to reduced bladder and breast cancers
• Goji berries and Macu Guard supplement are rich natural zeaxanthin sources
• Evidence remains associative; causation between zeaxanthin and cancer unproven

Summary

The video examines zeaxanthin, a carotenoid found in a popular eye‑health supplement, and its emerging profile as a possible adjunct in cancer therapy.

A recent pre‑clinical study showed that zeaxanthin can amplify the effect of immunotherapy drugs, while a series of epidemiological analyses report an inverse association between circulating zeaxanthin levels and overall cancer incidence. Observational data also suggest lower rates of bladder and breast cancers among individuals with higher dietary intake.

The presenter cites goji (wolf) berries and the commercial supplement Macu Guard as rich zeaxanthin sources, noting that dried goji berries contain especially high concentrations. He emphasizes that the evidence is largely associative, not yet proving causation.

If future trials confirm a therapeutic role, zeaxanthin could become a low‑cost, diet‑based complement to conventional oncology regimens, prompting both clinicians and consumers to reconsider nutrition‑focused prevention strategies.

Original Description

👀 Zeaxanthin may not just protect your eyes — it may also protect against cancer.

Across the broader literature, people who eat more zeaxanthin or have higher zeaxanthin levels in their blood tend to have a lower risk of certain cancers.

A large, long-term study in women followed zeaxanthin intake over 14 years and the highest intake group had a meaningful reduction in overall breast cancer risk compared with those in the lowest intake group.

Researchers also compared four animal groups with tumors: no treatment, zeaxanthin alone, or with immunotherapy (+/- zeaxanthin)

The combination produced the largest reduction in tumor size.

The cancer evidence is not yet as strong or direct as the eye-health data.

There is not yet a randomized trial where people are given zeaxanthin and followed for cancer incidence.

🍒 There is one food that stands out as a zeaxanthin powerhouse: the wolfberry.

Around 10 grams of dried goji berries per day is enough to put you into the high zeaxanthin intake range seen in protective human studies.

⚠️ Wolfberries can interact with certain medications, particularly blood-pressure drugs, blood thinners, and similar prescriptions.

If you are taking these, check with your physician before making goji berries a daily habit.

Main Points:

Zeaxanthin has direct human trial evidence for eye health, while the cancer evidence comes from observational studies in humans plus mechanistic and animal studies.

Higher zeaxanthin intake is associated with lower cancer risk, especially for breast cancer, and goji berries are a concentrated food source of zeaxanthin.

References:

617. Zhang FQ, Cell Rep Med, 2025. doi:10.1016/j.xcrm.2025.102324.

618. Zhang S, J Natl Cancer Inst, 1999. doi:10.1093/jnci/91.6.547.

619. Hung RJ, J Urol, 2006. doi:10.1016/j.juro.2006.04.030.

620. Eliassen AH, J Natl Cancer Inst, 2012. doi:10.1093/jnci/djs461.

621. Bakker MF, Am J Clin Nutr, 2016. doi:10.3945/ajcn.114.101659.